There are reports depicting the expression and oncogenic role of EIF5A2 in hepatocellular carcinoma, and EIF5A2 has been suggested to modulate several pathophysiological processes by promoting cell proliferation and cell metastasis by inducing epithelial-mesenchymal transition (EMT)24, 25. Here, EIF5A2 is linked to hepatocellular carcinoma.